Skip to content

Evaluation of healing effects of topical Liqurice ,geranium and myrtus on Shingles symptoms

Evaluation of healing effects of topical Liqurice preparation containing geranium and myrtus essential oil on Shingles symptoms in volunteered patients

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220123053800N1
Enrollment
40
Registered
2022-11-26
Start date
2021-04-09
Completion date
Unknown
Last updated
2023-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shingles or varicella zoster virus. Zoster [herpes zoster]

Interventions

Control group: received the classic treatment of shingles. Intervention group: received the classic treatment of shingles along with using the prepared product three times a day..

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Be over eighteen years old They have referred to Sedigheh Tahereh Dermatologist and Seeker or Al-Zahra Hospital Dermatology Clinic

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain score in the active phase of the disease and in nerve pain after shingles recovery. Timepoint: First: time of visit, second: three weeks later, third: twelve weeks later. Method of measurement: The graph is determined and evaluated according to VAS score from zero to ten (in the numerical range zero = no pain and ten = unbearable pain).

Secondary

MeasureTime frame
The score of the outward symptoms of the active phase of the disease. Timepoint: First: time of visit, second: three weeks later, third: twelve weeks later. Method of measurement: The variable is determined and evaluated according to the Likert scale from one to five (in the numerical range of one = very low and five = very high).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFateme asgari

Esfahan University of Medical Sciences

F.asgari7422@gmail.com+98 21 7795 2052

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026